Kronos Worldwide (NYSE:KRO - Get Free Report) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating in a research report issued on Thursday.
Other equities research analysts have also issued reports about the stock. The Goldman Sachs Group increased their target price on shares of Kronos Worldwide from $7.00 to $8.00 and gave the stock a "sell" rating in a report on Thursday, December 14th. Barclays boosted their price objective on shares of Kronos Worldwide from $7.00 to $8.00 and gave the stock an "underweight" rating in a research note on Tuesday, March 26th. Finally, TheStreet raised Kronos Worldwide from a "d+" rating to a "c-" rating in a report on Monday, March 11th.
Read Our Latest Stock Report on Kronos Worldwide
Kronos Worldwide Stock Performance
Shares of KRO stock traded down $0.09 during mid-day trading on Thursday, reaching $11.79. The stock had a trading volume of 135,912 shares, compared to its average volume of 253,113. Kronos Worldwide has a one year low of $6.16 and a one year high of $12.48. The company has a quick ratio of 1.49, a current ratio of 3.01 and a debt-to-equity ratio of 0.57. The firm's 50 day simple moving average is $10.27 and its 200 day simple moving average is $9.08. The firm has a market cap of $1.36 billion, a PE ratio of -27.42 and a beta of 1.21.
Kronos Worldwide (NYSE:KRO - Get Free Report) last announced its quarterly earnings results on Wednesday, March 6th. The specialty chemicals company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.02. Kronos Worldwide had a negative net margin of 2.95% and a negative return on equity of 5.73%. The firm had revenue of $400.10 million during the quarter, compared to the consensus estimate of $404.94 million. On average, analysts forecast that Kronos Worldwide will post 0.33 EPS for the current year.
Institutional Trading of Kronos Worldwide
Institutional investors have recently made changes to their positions in the company. UBS Asset Management Americas Inc. raised its stake in shares of Kronos Worldwide by 1.8% in the second quarter. UBS Asset Management Americas Inc. now owns 39,698 shares of the specialty chemicals company's stock valued at $730,000 after buying an additional 692 shares during the period. BNP Paribas Arbitrage SA raised its position in Kronos Worldwide by 25.7% during the second quarter. BNP Paribas Arbitrage SA now owns 5,256 shares of the specialty chemicals company's stock valued at $97,000 after purchasing an additional 1,073 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Kronos Worldwide by 0.7% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 165,792 shares of the specialty chemicals company's stock worth $1,447,000 after buying an additional 1,143 shares during the last quarter. Advisor Group Holdings Inc. grew its holdings in shares of Kronos Worldwide by 13.9% during the 4th quarter. Advisor Group Holdings Inc. now owns 10,193 shares of the specialty chemicals company's stock valued at $95,000 after purchasing an additional 1,245 shares during the last quarter. Finally, Raymond James & Associates increased its holdings in shares of Kronos Worldwide by 2.3% in the first quarter. Raymond James & Associates now owns 60,411 shares of the specialty chemicals company's stock worth $938,000 after buying an additional 1,350 shares during the period. Institutional investors own 15.11% of the company's stock.
Kronos Worldwide Company Profile
(
Get Free Report)
Kronos Worldwide, Inc produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kronos Worldwide, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kronos Worldwide wasn't on the list.
While Kronos Worldwide currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
